**The Board of Editors and the International Network of Critical Illness and Injury Trial Experts (INCIITE) in partnership with Medknow Publications and Media Pvt. Ltd. proudly present the inaugural issue of the International Journal of Critical Illness and Injury Science (IJCIIS).**

IJCIIS will promote the translation of science from bedside to benchside and beyond this connecting cells, clinics, and communities to synergize basic science, clinical medicine, and global health in the field of critical illness and injury sciences across the world.

THE SCOPE OF TRANSLATION SCIENCE {#sec1-1}
================================

Today the time has come that basic scientists need to work side by side with clinical researchers and public health experts to advance science which is helpful to the health of humanity. With this unique interaction between basic scientists, public health experts, and clinicians the discoveries made in laboratories can be applied to human situations on a population basis.

It is known that investigations and interventions with human health are a result of scientific studies from genetics, cell biology, and animal research. This knowledge is then translated to create diagnostic and therapeutic advances and innovations. The mission of translational research is to incorporate the discoveries from basic science areas into clinical investigations and public health studies and to use the results to generate research topics for basic science. JGID will promote such novel research.

Critical illness and injury research has its foundations in basic laboratory medicine. Translational research is considered the pathway of application for ideas and innovations from basic science studies to the diagnosis, treatment, and prevention of human disease. This area is the most dynamic and active scientific discipline. In 2005, "better translation of findings into patient care through guidelines" was at the top of the list of seven research priorities of the CDC, USA.

Our editorial team has been meticulously chosen from critical illness and injury experts around the globe and spans people from areas of trauma, emergency medicine, toxicology, inflammation biology, nanobiogenomics, resucitation science, global healh, health policy, clinical research and infectious diseases. Newer areas of nanotechnology, Computational Biology and emergency intelligence have also been incorporated.

We will publish scientific contributions such as Original Articles, Review Articles, Case Reports, Case Series, Clinical Trials, Clinical Investigations, Interesting Photographs, Radiology and EKGs, and Expert Commentaries. The journal is peer reviewed and indexed. Article submission and peer review is fully online and web based.

We believe that science will grow if shared and hence we are keeping IJCIIS as open access.

We invite clinicians, nurses, basic scientists, public health experts and policy makers to join our mission and use IJCIIS as a vehicle to publish their research, commentaries, and experiences thus bringing the global scientific community together.

IJCIIS Aims to achieve, sustain and redefineDistinction! {#sec2-1}
--------------------------------------------------------

There is a quote by Mark Sanborn in "The marks of distinction" where he emphasizes the need for growing oneself in order to grow the people around one. The resulting success of that growth comes from the ability of leaders and their team and he further adds that this growth should be channelized to offer and achieve excellence in areas, which are distinctive.

We believe and state that IJCIIS aims to achieve, sustain, and redefine distinction!

FURTHER INFORMATION {#sec1-2}
===================

*International Journal of Critical Illness and Injury Science (IJCIIS) is the official journal of the International Network of Critical Illness and Injury Trial Experts*.

IJCIIS encourages research, education, and dissemination of knowledge in the fields of Intensive Medicine, Emergency Care, Resuscitation, and Rescue and Rehabilitation thus promoting translational research by striking a synergy between basic science, clinical medicine, and global health.

IJCIIS aims for a wider dissemination of information and sharing of knowledge. Hence, the journal would not be restricted to its print edition or subscribers of the journal. IJCIIS will be available to anyone who has internet access for reading, download, and printing. This access will not be limited for any particular period but would be perpetual.

The journal will be published semiannually (June and December) in 2011, three times a year in 2012 (January, May, and September) and quarterly from 2013 (January, April, July, and October). Though the issues are published on fixed schedules, IJCIIS would publish articles on its web site immediately on acceptance.

Though IJCIIS holds the copyright of its contents, it allows authors and readers to use its material for scientific, noncommercial purposes, without requiring taking permission from its editor or publisher.

Medknow Publications and Media Pvt. Ltd., a publisher of open access, peer-reviewed scientific journals, is committed to the improving the visibility and accessibility of the science from the developing world. Its endeavor in continuously reinventing the publishing methodology for about a decade has resulted in high-quality, peer-reviewed scholarly journals. Medknow pioneers in the "fee--less--free" model of open access publishing and provides immediate free access to the electronic editions of the journals without charging the author or author\'s institution for submission, processing, or publication of the articles. Medknow, with over 150 print+ online journals, is probably the largest open access publisher of print journals in the world which does not charge the author or author institution for submission, processing, or publication of articles. Each journal published by Medknow has its independent website. The websites use the OpenURL standard, making it easy for libraries to link users as directly as possible from the citation to the full text of the article. These journals are searchable from DOAJ ([www.doaj.org](www.doaj.org)) and are part of HINARI. All the journals provide RSS feeds which is also ATOM enabled. All the issues are also available in the XML format. The open access policy has resulted in more than a half a million article downloads in a month for all the journals.
